http://www.streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Wed, 13 May 2026 16:22:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://www.streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Cytosorbents+Corp+++++++++For%3A+Mar+31/26486477.html si-local-file:///var/storage/secattach/20260513/26486477.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Cytosorbents+Corp+++++++++For%3A+Mar+31/26486477.html Wed, 13 May 2026 16:22:00 -0400 CTSO O.03158501 http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Cytosorbents+Corp+++++++++For%3A+Mar+31/26486477.html si-local-file:///var/storage/secattach/20260513/26486477.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Cytosorbents+Corp+++++++++For%3A+Mar+31/26486477.html Wed, 13 May 2026 16:22:00 -0400 CTSO O.03158501 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Cytosorbents+Corp+++++++++For%3A+May+13/26485886.html si-local-file:///var/storage/secattach/20260513/26485886.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Cytosorbents+Corp+++++++++For%3A+May+13/26485886.html Wed, 13 May 2026 16:06:00 -0400 CTSO O.03158501 http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Cytosorbents+Corp+++++++++For%3A+May+13/26485886.html si-local-file:///var/storage/secattach/20260513/26485886.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Cytosorbents+Corp+++++++++For%3A+May+13/26485886.html Wed, 13 May 2026 16:06:00 -0400 CTSO O.03158501 http://www.streetinsider.com/Earnings/Cytosorbents+%28CTSO%29+Misses+Q1+EPS+by+1c/26485643.html <p>Cytosorbents (NASDAQ: CTSO) reported Q1 EPS of ($0.05), $0.01 worse than the analyst estimate of ($0.04). Revenue for the quarter came in at $8.9 million versus the consensus estimate of $9.23 million.</p> <p>For earnings history and earnings-related data on Cytosorbents (CTSO) <a href="http://www.streetinsider.com/ec_earnings.php?q=CTSO">click here</a>.</p> http://www.streetinsider.com/Earnings/Cytosorbents+%28CTSO%29+Misses+Q1+EPS+by+1c/26485643.html Wed, 13 May 2026 16:00:49 -0400 CTSO http://www.streetinsider.com/Press+Releases/CytoSorbents+Reports+First+Quarter+2026+Financial+Results%2C+Recent+Business+Highlights%2C+and+Regulatory+Update/26485622.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.nj.prnctn" idsrc="xmltag.org" >PRINCETON, N.J.</location></span>, <span class="legendSpanClass"><chron>May 13, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4688270-1&amp;h=2389745047&amp;u=http%3A%2F%2Fwww.cytosorbents.com%2F&amp;a=CytoSorbents+Corporation" target="_blank" rel="nofollow"><span value="NASDAQ-SMALL:CTSO" idsrc="xmltag.org" >CytoSorbents Corporation</span></a> (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today reported financial results for the first quarter ended March 31, 2026, recent business highlights, and provides a regulatory update. </p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/CytoSorbents+Reports+First+Quarter+2026+Financial+Results%2C+Recent+Business+Highlights%2C+and+Regulatory+Update/26485622.html Wed, 13 May 2026 16:00:00 -0400 A.06822034 A.17150087 A.19651963 CTSO O.03158501 O.20026344 O.21314198 O.34929518 http://www.streetinsider.com/Press+Releases/CytoSorbents+Reports+First+Quarter+2026+Financial+Results%2C+Recent+Business+Highlights%2C+and+Regulatory+Update/26485622.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.nj.prnctn" idsrc="xmltag.org" >PRINCETON, N.J.</location></span>, <span class="legendSpanClass"><chron>May 13, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4688270-1&amp;h=2389745047&amp;u=http%3A%2F%2Fwww.cytosorbents.com%2F&amp;a=CytoSorbents+Corporation" target="_blank" rel="nofollow"><span value="NASDAQ-SMALL:CTSO" idsrc="xmltag.org" >CytoSorbents Corporation</span></a> (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today reported financial results for the first quarter ended March 31, 2026, recent business highlights, and provides a regulatory update. </p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/CytoSorbents+Reports+First+Quarter+2026+Financial+Results%2C+Recent+Business+Highlights%2C+and+Regulatory+Update/26485622.html Wed, 13 May 2026 16:00:00 -0400 A.06822034 A.17150087 A.19651963 CTSO O.03158501 O.20026344 O.21314198 O.34929518 http://www.streetinsider.com/Press+Releases/CytoSorbents+Reports+First+Quarter+2026+Financial+Results%2C+Recent+Business+Highlights%2C+and+Regulatory+Update/26485622.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.nj.prnctn" idsrc="xmltag.org" >PRINCETON, N.J.</location></span>, <span class="legendSpanClass"><chron>May 13, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4688270-1&amp;h=2389745047&amp;u=http%3A%2F%2Fwww.cytosorbents.com%2F&amp;a=CytoSorbents+Corporation" target="_blank" rel="nofollow"><span value="NASDAQ-SMALL:CTSO" idsrc="xmltag.org" >CytoSorbents Corporation</span></a> (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today reported financial results for the first quarter ended March 31, 2026, recent business highlights, and provides a regulatory update. </p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/CytoSorbents+Reports+First+Quarter+2026+Financial+Results%2C+Recent+Business+Highlights%2C+and+Regulatory+Update/26485622.html Wed, 13 May 2026 16:00:00 -0400 A.06822034 A.17150087 A.19651963 CTSO O.03158501 O.20026344 O.21314198 O.34929518 http://www.streetinsider.com/Press+Releases/CytoSorbents+Reports+First+Quarter+2026+Financial+Results%2C+Recent+Business+Highlights%2C+and+Regulatory+Update/26485622.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.nj.prnctn" idsrc="xmltag.org" >PRINCETON, N.J.</location></span>, <span class="legendSpanClass"><chron>May 13, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4688270-1&amp;h=2389745047&amp;u=http%3A%2F%2Fwww.cytosorbents.com%2F&amp;a=CytoSorbents+Corporation" target="_blank" rel="nofollow"><span value="NASDAQ-SMALL:CTSO" idsrc="xmltag.org" >CytoSorbents Corporation</span></a> (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today reported financial results for the first quarter ended March 31, 2026, recent business highlights, and provides a regulatory update. </p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/CytoSorbents+Reports+First+Quarter+2026+Financial+Results%2C+Recent+Business+Highlights%2C+and+Regulatory+Update/26485622.html Wed, 13 May 2026 16:00:00 -0400 A.06822034 A.17150087 A.19651963 CTSO O.03158501 O.20026344 O.21314198 O.34929518 http://www.streetinsider.com/Press+Releases/CytoSorbents+Reports+First+Quarter+2026+Financial+Results%2C+Recent+Business+Highlights%2C+and+Regulatory+Update/26485622.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.nj.prnctn" idsrc="xmltag.org" >PRINCETON, N.J.</location></span>, <span class="legendSpanClass"><chron>May 13, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4688270-1&amp;h=2389745047&amp;u=http%3A%2F%2Fwww.cytosorbents.com%2F&amp;a=CytoSorbents+Corporation" target="_blank" rel="nofollow"><span value="NASDAQ-SMALL:CTSO" idsrc="xmltag.org" >CytoSorbents Corporation</span></a> (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today reported financial results for the first quarter ended March 31, 2026, recent business highlights, and provides a regulatory update. </p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/CytoSorbents+Reports+First+Quarter+2026+Financial+Results%2C+Recent+Business+Highlights%2C+and+Regulatory+Update/26485622.html Wed, 13 May 2026 16:00:00 -0400 A.06822034 A.17150087 A.19651963 CTSO O.03158501 O.20026344 O.21314198 O.34929518 http://www.streetinsider.com/Press+Releases/CytoSorbents+Reports+First+Quarter+2026+Financial+Results%2C+Recent+Business+Highlights%2C+and+Regulatory+Update/26485622.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.nj.prnctn" idsrc="xmltag.org" >PRINCETON, N.J.</location></span>, <span class="legendSpanClass"><chron>May 13, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4688270-1&amp;h=2389745047&amp;u=http%3A%2F%2Fwww.cytosorbents.com%2F&amp;a=CytoSorbents+Corporation" target="_blank" rel="nofollow"><span value="NASDAQ-SMALL:CTSO" idsrc="xmltag.org" >CytoSorbents Corporation</span></a> (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today reported financial results for the first quarter ended March 31, 2026, recent business highlights, and provides a regulatory update. </p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/CytoSorbents+Reports+First+Quarter+2026+Financial+Results%2C+Recent+Business+Highlights%2C+and+Regulatory+Update/26485622.html Wed, 13 May 2026 16:00:00 -0400 A.06822034 A.17150087 A.19651963 CTSO O.03158501 O.20026344 O.21314198 O.34929518 http://www.streetinsider.com/Press+Releases/CytoSorbents+Reports+First+Quarter+2026+Financial+Results%2C+Recent+Business+Highlights%2C+and+Regulatory+Update/26485622.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.nj.prnctn" idsrc="xmltag.org" >PRINCETON, N.J.</location></span>, <span class="legendSpanClass"><chron>May 13, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4688270-1&amp;h=2389745047&amp;u=http%3A%2F%2Fwww.cytosorbents.com%2F&amp;a=CytoSorbents+Corporation" target="_blank" rel="nofollow"><span value="NASDAQ-SMALL:CTSO" idsrc="xmltag.org" >CytoSorbents Corporation</span></a> (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today reported financial results for the first quarter ended March 31, 2026, recent business highlights, and provides a regulatory update. </p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/CytoSorbents+Reports+First+Quarter+2026+Financial+Results%2C+Recent+Business+Highlights%2C+and+Regulatory+Update/26485622.html Wed, 13 May 2026 16:00:00 -0400 A.06822034 A.17150087 A.19651963 CTSO O.03158501 O.20026344 O.21314198 O.34929518 http://www.streetinsider.com/Press+Releases/CytoSorbents+Reports+First+Quarter+2026+Financial+Results%2C+Recent+Business+Highlights%2C+and+Regulatory+Update/26485622.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.nj.prnctn" idsrc="xmltag.org" >PRINCETON, N.J.</location></span>, <span class="legendSpanClass"><chron>May 13, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4688270-1&amp;h=2389745047&amp;u=http%3A%2F%2Fwww.cytosorbents.com%2F&amp;a=CytoSorbents+Corporation" target="_blank" rel="nofollow"><span value="NASDAQ-SMALL:CTSO" idsrc="xmltag.org" >CytoSorbents Corporation</span></a> (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today reported financial results for the first quarter ended March 31, 2026, recent business highlights, and provides a regulatory update. </p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/CytoSorbents+Reports+First+Quarter+2026+Financial+Results%2C+Recent+Business+Highlights%2C+and+Regulatory+Update/26485622.html Wed, 13 May 2026 16:00:00 -0400 A.06822034 A.17150087 A.19651963 CTSO O.03158501 O.20026344 O.21314198 O.34929518 http://www.streetinsider.com/PRNewswire/CytoSorbents+Reports+First+Quarter+2026+Financial+Results%2C+Recent+Business+Highlights%2C+and+Regulatory+Update/26485622.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.nj.prnctn" idsrc="xmltag.org" >PRINCETON, N.J.</location></span>, <span class="legendSpanClass"><chron>May 13, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4688270-1&amp;h=2389745047&amp;u=http%3A%2F%2Fwww.cytosorbents.com%2F&amp;a=CytoSorbents+Corporation" target="_blank" rel="nofollow"><span value="NASDAQ-SMALL:CTSO" idsrc="xmltag.org" >CytoSorbents Corporation</span></a> (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today reported financial results for the first quarter ended March 31, 2026, recent business highlights, and provides a regulatory update. </p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/PRNewswire/CytoSorbents+Reports+First+Quarter+2026+Financial+Results%2C+Recent+Business+Highlights%2C+and+Regulatory+Update/26485622.html Wed, 13 May 2026 16:00:00 -0400 A.06822034 A.17150087 A.19651963 CTSO O.03158501 O.20026344 O.21314198 O.34929518 http://www.streetinsider.com/PRNewswire/CytoSorbents+Reports+First+Quarter+2026+Financial+Results%2C+Recent+Business+Highlights%2C+and+Regulatory+Update/26485622.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.nj.prnctn" idsrc="xmltag.org" >PRINCETON, N.J.</location></span>, <span class="legendSpanClass"><chron>May 13, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4688270-1&amp;h=2389745047&amp;u=http%3A%2F%2Fwww.cytosorbents.com%2F&amp;a=CytoSorbents+Corporation" target="_blank" rel="nofollow"><span value="NASDAQ-SMALL:CTSO" idsrc="xmltag.org" >CytoSorbents Corporation</span></a> (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today reported financial results for the first quarter ended March 31, 2026, recent business highlights, and provides a regulatory update. </p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/PRNewswire/CytoSorbents+Reports+First+Quarter+2026+Financial+Results%2C+Recent+Business+Highlights%2C+and+Regulatory+Update/26485622.html Wed, 13 May 2026 16:00:00 -0400 A.06822034 A.17150087 A.19651963 CTSO O.03158501 O.20026344 O.21314198 O.34929518 http://www.streetinsider.com/PRNewswire/CytoSorbents+Reports+First+Quarter+2026+Financial+Results%2C+Recent+Business+Highlights%2C+and+Regulatory+Update/26485622.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.nj.prnctn" idsrc="xmltag.org" >PRINCETON, N.J.</location></span>, <span class="legendSpanClass"><chron>May 13, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4688270-1&amp;h=2389745047&amp;u=http%3A%2F%2Fwww.cytosorbents.com%2F&amp;a=CytoSorbents+Corporation" target="_blank" rel="nofollow"><span value="NASDAQ-SMALL:CTSO" idsrc="xmltag.org" >CytoSorbents Corporation</span></a> (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today reported financial results for the first quarter ended March 31, 2026, recent business highlights, and provides a regulatory update. </p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/PRNewswire/CytoSorbents+Reports+First+Quarter+2026+Financial+Results%2C+Recent+Business+Highlights%2C+and+Regulatory+Update/26485622.html Wed, 13 May 2026 16:00:00 -0400 A.06822034 A.17150087 A.19651963 CTSO O.03158501 O.20026344 O.21314198 O.34929518 http://www.streetinsider.com/PRNewswire/CytoSorbents+Reports+First+Quarter+2026+Financial+Results%2C+Recent+Business+Highlights%2C+and+Regulatory+Update/26485622.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.nj.prnctn" idsrc="xmltag.org" >PRINCETON, N.J.</location></span>, <span class="legendSpanClass"><chron>May 13, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4688270-1&amp;h=2389745047&amp;u=http%3A%2F%2Fwww.cytosorbents.com%2F&amp;a=CytoSorbents+Corporation" target="_blank" rel="nofollow"><span value="NASDAQ-SMALL:CTSO" idsrc="xmltag.org" >CytoSorbents Corporation</span></a> (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today reported financial results for the first quarter ended March 31, 2026, recent business highlights, and provides a regulatory update. </p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/PRNewswire/CytoSorbents+Reports+First+Quarter+2026+Financial+Results%2C+Recent+Business+Highlights%2C+and+Regulatory+Update/26485622.html Wed, 13 May 2026 16:00:00 -0400 A.06822034 A.17150087 A.19651963 CTSO O.03158501 O.20026344 O.21314198 O.34929518 http://www.streetinsider.com/PRNewswire/CytoSorbents+Reports+First+Quarter+2026+Financial+Results%2C+Recent+Business+Highlights%2C+and+Regulatory+Update/26485622.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.nj.prnctn" idsrc="xmltag.org" >PRINCETON, N.J.</location></span>, <span class="legendSpanClass"><chron>May 13, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4688270-1&amp;h=2389745047&amp;u=http%3A%2F%2Fwww.cytosorbents.com%2F&amp;a=CytoSorbents+Corporation" target="_blank" rel="nofollow"><span value="NASDAQ-SMALL:CTSO" idsrc="xmltag.org" >CytoSorbents Corporation</span></a> (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today reported financial results for the first quarter ended March 31, 2026, recent business highlights, and provides a regulatory update. </p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/PRNewswire/CytoSorbents+Reports+First+Quarter+2026+Financial+Results%2C+Recent+Business+Highlights%2C+and+Regulatory+Update/26485622.html Wed, 13 May 2026 16:00:00 -0400 A.06822034 A.17150087 A.19651963 CTSO O.03158501 O.20026344 O.21314198 O.34929518 http://www.streetinsider.com/PRNewswire/CytoSorbents+Reports+First+Quarter+2026+Financial+Results%2C+Recent+Business+Highlights%2C+and+Regulatory+Update/26485622.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.nj.prnctn" idsrc="xmltag.org" >PRINCETON, N.J.</location></span>, <span class="legendSpanClass"><chron>May 13, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4688270-1&amp;h=2389745047&amp;u=http%3A%2F%2Fwww.cytosorbents.com%2F&amp;a=CytoSorbents+Corporation" target="_blank" rel="nofollow"><span value="NASDAQ-SMALL:CTSO" idsrc="xmltag.org" >CytoSorbents Corporation</span></a> (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today reported financial results for the first quarter ended March 31, 2026, recent business highlights, and provides a regulatory update. </p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/PRNewswire/CytoSorbents+Reports+First+Quarter+2026+Financial+Results%2C+Recent+Business+Highlights%2C+and+Regulatory+Update/26485622.html Wed, 13 May 2026 16:00:00 -0400 A.06822034 A.17150087 A.19651963 CTSO O.03158501 O.20026344 O.21314198 O.34929518 http://www.streetinsider.com/PRNewswire/CytoSorbents+Reports+First+Quarter+2026+Financial+Results%2C+Recent+Business+Highlights%2C+and+Regulatory+Update/26485622.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.nj.prnctn" idsrc="xmltag.org" >PRINCETON, N.J.</location></span>, <span class="legendSpanClass"><chron>May 13, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4688270-1&amp;h=2389745047&amp;u=http%3A%2F%2Fwww.cytosorbents.com%2F&amp;a=CytoSorbents+Corporation" target="_blank" rel="nofollow"><span value="NASDAQ-SMALL:CTSO" idsrc="xmltag.org" >CytoSorbents Corporation</span></a> (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today reported financial results for the first quarter ended March 31, 2026, recent business highlights, and provides a regulatory update. </p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/PRNewswire/CytoSorbents+Reports+First+Quarter+2026+Financial+Results%2C+Recent+Business+Highlights%2C+and+Regulatory+Update/26485622.html Wed, 13 May 2026 16:00:00 -0400 A.06822034 A.17150087 A.19651963 CTSO O.03158501 O.20026344 O.21314198 O.34929518 http://www.streetinsider.com/PRNewswire/CytoSorbents+Reports+First+Quarter+2026+Financial+Results%2C+Recent+Business+Highlights%2C+and+Regulatory+Update/26485622.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.nj.prnctn" idsrc="xmltag.org" >PRINCETON, N.J.</location></span>, <span class="legendSpanClass"><chron>May 13, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4688270-1&amp;h=2389745047&amp;u=http%3A%2F%2Fwww.cytosorbents.com%2F&amp;a=CytoSorbents+Corporation" target="_blank" rel="nofollow"><span value="NASDAQ-SMALL:CTSO" idsrc="xmltag.org" >CytoSorbents Corporation</span></a> (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, today reported financial results for the first quarter ended March 31, 2026, recent business highlights, and provides a regulatory update. </p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/PRNewswire/CytoSorbents+Reports+First+Quarter+2026+Financial+Results%2C+Recent+Business+Highlights%2C+and+Regulatory+Update/26485622.html Wed, 13 May 2026 16:00:00 -0400 A.06822034 A.17150087 A.19651963 CTSO O.03158501 O.20026344 O.21314198 O.34929518 http://www.streetinsider.com/Press+Releases/CytoSorbents+to+Report+First+Quarter+2026+Financial+Results+and+Recent+Business+Highlights/26400244.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.nj.prnctn" idsrc="xmltag.org" >PRINCETON, N.J.</location></span>, <span class="legendSpanClass"><chron>April 30, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4677115-1&amp;h=2949418896&amp;u=http%3A%2F%2Fwww.cytosorbents.com%2F&amp;a=CytoSorbents+Corporation" target="_blank" rel="nofollow"><span value="NASDAQ-SMALL:CTSO" idsrc="xmltag.org" >CytoSorbents Corporation</span></a> (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, will report first quarter 2026 financial results and recent business highlights after the market close on <chron>Wednesday, May 13, 2026</chron>.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/CytoSorbents+to+Report+First+Quarter+2026+Financial+Results+and+Recent+Business+Highlights/26400244.html Thu, 30 Apr 2026 07:00:00 -0400 CTSO O.03158501 http://www.streetinsider.com/Press+Releases/CytoSorbents+to+Report+First+Quarter+2026+Financial+Results+and+Recent+Business+Highlights/26400244.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.nj.prnctn" idsrc="xmltag.org" >PRINCETON, N.J.</location></span>, <span class="legendSpanClass"><chron>April 30, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4677115-1&amp;h=2949418896&amp;u=http%3A%2F%2Fwww.cytosorbents.com%2F&amp;a=CytoSorbents+Corporation" target="_blank" rel="nofollow"><span value="NASDAQ-SMALL:CTSO" idsrc="xmltag.org" >CytoSorbents Corporation</span></a> (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, will report first quarter 2026 financial results and recent business highlights after the market close on <chron>Wednesday, May 13, 2026</chron>.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/Press+Releases/CytoSorbents+to+Report+First+Quarter+2026+Financial+Results+and+Recent+Business+Highlights/26400244.html Thu, 30 Apr 2026 07:00:00 -0400 CTSO O.03158501 http://www.streetinsider.com/PRNewswire/CytoSorbents+to+Report+First+Quarter+2026+Financial+Results+and+Recent+Business+Highlights/26400244.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.nj.prnctn" idsrc="xmltag.org" >PRINCETON, N.J.</location></span>, <span class="legendSpanClass"><chron>April 30, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4677115-1&amp;h=2949418896&amp;u=http%3A%2F%2Fwww.cytosorbents.com%2F&amp;a=CytoSorbents+Corporation" target="_blank" rel="nofollow"><span value="NASDAQ-SMALL:CTSO" idsrc="xmltag.org" >CytoSorbents Corporation</span></a> (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, will report first quarter 2026 financial results and recent business highlights after the market close on <chron>Wednesday, May 13, 2026</chron>.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/PRNewswire/CytoSorbents+to+Report+First+Quarter+2026+Financial+Results+and+Recent+Business+Highlights/26400244.html Thu, 30 Apr 2026 07:00:00 -0400 CTSO O.03158501 http://www.streetinsider.com/PRNewswire/CytoSorbents+to+Report+First+Quarter+2026+Financial+Results+and+Recent+Business+Highlights/26400244.html <div class="xn-content"> <p><span class="legendSpanClass"><location value="LU/us.nj.prnctn" idsrc="xmltag.org" >PRINCETON, N.J.</location></span>, <span class="legendSpanClass"><chron>April 30, 2026</chron></span> /PRNewswire/ -- <a target="_blank" href="https://edge.prnewswire.com/c/link/?t=0&amp;l=en&amp;o=4677115-1&amp;h=2949418896&amp;u=http%3A%2F%2Fwww.cytosorbents.com%2F&amp;a=CytoSorbents+Corporation" target="_blank" rel="nofollow"><span value="NASDAQ-SMALL:CTSO" idsrc="xmltag.org" >CytoSorbents Corporation</span></a> (NASDAQ: CTSO), a leader in the treatment of life-threatening conditions in the intensive care unit and cardiac surgery using blood purification, will report first quarter 2026 financial results and recent business highlights after the market close on <chron>Wednesday, May 13, 2026</chron>.</p> <div class="PRN_ImbeddedAssetReference" id="DivAssetPlaceHolder1"> <p> http://www.streetinsider.com/PRNewswire/CytoSorbents+to+Report+First+Quarter+2026+Financial+Results+and+Recent+Business+Highlights/26400244.html Thu, 30 Apr 2026 07:00:00 -0400 CTSO O.03158501